We are live on ! Find out more
HOOK

HOOKIPA Pharma
HOOK

Delisted

HOOK was delisted on the 7th of August, 2025.

Back to rankings

41 hedge funds and large institutions have $29.4M invested in HOOKIPA Pharma in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

189% more call options, than puts

Call options by funds: $52K | Put options by funds: $18K

14% more capital invested

Capital invested by funds: $25.7M → $29.4M (+$3.69M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.67% less ownership

Funds ownership: 5.12% → 4.45% (-0.67%)

7% less funds holding

Funds holding: 44 → 41 (-3)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
41
Holders Change
-3
Holders Change %
-6.82%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
7
Increased
8
Reduced
11
Closed
10
Calls
$52K
Puts
$18K
Net Calls
+$34K
Net Calls Change
+$50K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$952K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$164K
3
TSS
Two Sigma Securities
New York
+$45.3K
4
BBA
Baker Bros. Advisors
New York
+$34.6K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$28.9K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.29M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.92M
3
Renaissance Technologies
Renaissance Technologies
New York
-$202K
4
Two Sigma Investments
Two Sigma Investments
New York
-$135K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$110K
Name Holding Trade Value Shares
Change 		Change in
Stake
BPA
26
Beacon Pointe Advisors
California
$19K -$881 -160 -6%
AC
27
Apella Capital
Connecticut
$14.9K +$10.9K +1,978 New
Group One Trading
28
Group One Trading
Illinois
$14.1K -$19.1K -3,468 -67%
Two Sigma Investments
29
Two Sigma Investments
New York
$13K -$135K -24,429 -94%
IAIM
30
International Assets Investment Management
Florida
$11.3K +$7.71K +1,400 New
TRCT
31
Tower Research Capital (TRC)
New York
$7.8K -$2.59K -470 -33%
NS
32
NBC Securities
Alabama
$7K +$1.1K +200 +27%
Bank of America
33
Bank of America
North Carolina
$5.23K -$61 -11 -2%
UBS Group
34
UBS Group
Switzerland
$4.73K +$3.18K +578 +9,633%
Osaic Holdings
35
Osaic Holdings
Arizona
$3.24K +$2.2K +400 New
Wells Fargo
36
Wells Fargo
California
$437 -$39 -7 -11%
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$273 – – –
FDCDDQ
38
Federation des caisses Desjardins du Quebec
Quebec, Canada
$267 – – –
Citigroup
39
Citigroup
New York
$60 – – –
JP Morgan Chase
40
JP Morgan Chase
New York
$11 – – –
ASN
41
Advisory Services Network
Georgia
$6 +$6 +1 New
AC
42
Armistice Capital
New York
– -$2.29M -371,200 Closed
Alyeska Investment Group
43
Alyeska Investment Group
Illinois
– -$1.92M -310,944 Closed
Vontobel Holding
44
Vontobel Holding
Switzerland
– -$27.7K -4,500 Closed
BCM
45
Bayesian Capital Management
New York
– -$8.91K -1,446 Closed
Simplex Trading
46
Simplex Trading
Illinois
– -$4.41K -800 Closed
Citadel Advisors
47
Citadel Advisors
Florida
– -$2.92K -474 Closed
US Bancorp
48
US Bancorp
Minnesota
– -$924 -150 Closed
Federated Hermes
49
Federated Hermes
Pennsylvania
– -$436 -71 Closed
BHWM
50
Beaird Harris Wealth Management
Texas
– -$57 -9 Closed
1
2
3

HOOK Hedge Fund Activity: Q4 2023 in Review

41 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2023, worth a combined $29.4M — up 14% from $25.7M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of HOOK and 7 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 8 added.

The largest buyer was Morgan Stanley, adding an estimated $952K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.29M sold.

  • 41 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2023, down from 44 in Q3 2023.
  • Funds reported $29.4M of HOOKIPA Pharma stock for Q4 2023, up 14% quarter-over-quarter.
  • 7 funds opened new HOOKIPA Pharma positions in Q4 2023 and 10 closed out, a net change of -3 holders.
  • The largest HOOKIPA Pharma buyer in Q4 2023 was Morgan Stanley, an estimated $952K added.
  • The largest HOOKIPA Pharma seller in Q4 2023 was Armistice Capital, an estimated $2.29M sold.

Based on aggregated 13F filings for Q4 2023.